Si Bone Ownership
| SIBN Stock | USD 18.78 0.29 1.57% |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 42 M | Current Value 42.5 M | Avarage Shares Outstanding 26.2 M | Quarterly Volatility 12.9 M |
SIBN Stock Ownership Analysis
About 94.0% of the company shares are owned by institutional investors. The book value of Si Bone was at this time reported as 3.94. The company recorded a loss per share of 0.63. Si Bone had not issued any dividends in recent years. The entity had 1:70 split on the March 15, 2011. SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Si Bone operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people. To find out more about Si Bone contact Laura MBA at 408 207 0700 or learn more at https://si-bone.com.SIBN Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Si Bone is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Si Bone backward and forwards among themselves. Si Bone's institutional investor refers to the entity that pools money to purchase Si Bone's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-12-31 | 1.1 M | Geode Capital Management, Llc | 2024-12-31 | 933.9 K | Bellevue Group Ag | 2024-12-31 | 881 K | Kent Lake Pr Llc | 2024-12-31 | 793.5 K | Impax Asset Management Group Plc | 2025-03-31 | 766.8 K | Victory Capital Management Inc. | 2025-03-31 | 631.6 K | Holocene Advisors, Lp | 2024-12-31 | 585.3 K | Harbor Capital Advisors Inc | 2025-03-31 | 532.7 K | Wellington Management Company Llp | 2024-12-31 | 504.7 K | Blackrock Inc | 2024-12-31 | 3.8 M | Brown Advisory Holdings Inc | 2024-12-31 | 3.6 M |
Si Bone Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Si Bone insiders, such as employees or executives, is commonly permitted as long as it does not rely on Si Bone's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Si Bone insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Si Bone Outstanding Bonds
Si Bone issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Si Bone uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SIBN bonds can be classified according to their maturity, which is the date when Si Bone has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Si Bone Corporate Filings
F4 | 9th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 6th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 5th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 25th of April 2025 Other Reports | ViewVerify |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share | Quarterly Revenue Growth 0.249 | Return On Assets | Return On Equity |
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.